GlaxoSmithKline starts hunt for successor to CEO Witty
LONDON, Feb 29 (Reuters) - GlaxoSmithKline's chairman is starting the process of seeking a new chief executive to succeed Andrew Witty, although a handover at the top of Britain's biggest drugmaker is not expected before 2017.
No comments:
Post a Comment